Authors: Nip, J Strom, DK Eischen, CM Cleveland, JL Zambetti, GP Hiebert, SW

Citation: J. Nip et al., E2F-1 induces the stabilization of p53 but blocks p53-mediated transactivation, ONCOGENE, 20(8), 2001, pp. 910-920

Authors: Eischen, CM Packham, G Nip, J Fee, BE Hiebert, SW Zambetti, GP Cleveland, JL

Citation: Cm. Eischen et al., Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1, ONCOGENE, 20(48), 2001, pp. 6983-6993

Authors: Amann, JM Nip, J Strom, DK Lutterbach, B Harada, H Lenny, N Downing, JR Meyers, S Hiebert, SW

Citation: Jm. Amann et al., ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain, MOL CELL B, 21(19), 2001, pp. 6470-6483

Authors: Khatib, AM Nip, J Fallavollita, L Lehmann, M Jensen, G Brodt, P

Citation: Am. Khatib et al., Regulation of urokinase plasminogen activator/plasmin-mediated invasion ofmelanoma cells by the integrin vitronectin receptor alpha(v)beta(3), INT J CANC, 91(3), 2001, pp. 300-308

Authors: Fenrick, R Wang, LL Nip, J Amann, JM Rooney, RJ Walker-Daniels, J Crawford, HC Hulboy, DL Kinch, MS Matrisian, LM Hiebert, SW

Citation: R. Fenrick et al., TEL, a putative tumor suppressor, modulates cell growth and cell morphology of Ras-transformed cells while repressing the transcription of stromelysin-1, MOL CELL B, 20(16), 2000, pp. 5828-5839